Skin antisepsis in the neonate: What should we use?

Current Opinion in Infectious Diseases

Volumn 27, Issue 3, 2014, Pages 244-250

  Ponnusamy, Vennila ^a   Venkatesh, Vidheya ^b   Clarke, Paul ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

catheter related sepsis; coagulase negative staphylococcus; extraluminal colonization; nosocomial sepsis; percutaneous central venous catheters

Indexed keywords

ALCOHOL DERIVATIVE; ANTIINFECTIVE AGENT; CHLORHEXIDINE GLUCONATE; EMOLLIENT AGENT; IODINE; TOPICAL ANTIINFECTIVE AGENT;

ANTISEPSIS; CATHETER INFECTION; CHEMICAL INJURY; COMPARATIVE STUDY; DRUG EFFICACY; GOLD STANDARD; GROUP B STREPTOCOCCAL INFECTION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY (TOPIC); NEWBORN CARE; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKIN INJURY; VERY LOW BIRTH WEIGHT; CATHETER; CROSS INFECTION; MICROBIOLOGY; NEWBORN; PREMATURITY; SKIN; UMBILICAL CORD;

ANTI-INFECTIVE AGENTS, LOCAL; CATHETERS; CROSS INFECTION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PRACTICE GUIDELINES AS TOPIC; SKIN; UMBILICAL CORD;

EID: 84900483886     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000064     Document Type: Review

References (68)

1. Polin RA, Saiman L. Nosocomial infections in the neonatal intensive care unit. NeoRev 2003; 4:e81-89.
2. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections, 2011. Clin Infect Dis 2011; 52:e162-193.
3. Gray JE, Richardson DK, McCormick MC, Goldmann DA. Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome. Pediatrics 1995; 95:225-230.
4. Brodie SB, Sands KE, Gray JE, et al. Occurrence of nosocomial bloodstream infections in six neonatal intensive care units. Pediatr Infect Dis J 2000; 19:56-65.
5. Weisman LE. Antibody for the prevention of neonatal noscocomial staphylococcal infection: a review of the literature. Arch Pediatr 2007; 14: S31-S34.
6. Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292:2357-2365.
7. Wheater M, Rennie JM. Perinatal infection is an important risk factor for cerebral palsy in very-low-birthweight infants. Dev Med Child Neurol 2000; 42:364-367.
8. Schlapbach LJ, Aebischer M, Adams M, et al. Impact of sepsis on neuro-developmental outcome in a Swiss National Cohort of extremely premature infants. Pediatrics 2011; 128:e348-357.
9. Chau V, Brant R, Poskitt KJ, et al. Postnatal infection is associated with ■ widespread abnormalities of brain development in premature newborns. Pediatr Res 2012; 71:274-279.
10. Bion J, Richardson A, Hibbert P, et al. 'Matching Michigan': a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England. BMJ Qual Saf 2013; 22:110-123.
11. Ness MJ, Davis DM, Carey WA. Neonatal skin care: a concise review. Int J Dermatol 2013; 52:14-22.
12. Hoath SB, Maibach HI, editors. Neonatal skin: structure and function, 2nd ed. New York: Marcel Dekker, Inc; 2003.
13. Keyworth N, Millar MR, Holland KT. Development of cutaneous microflora in premature neonates. Arch Dis Child 1992; 67:797-801.
14. Marchant EA, Boyce GK, Sadarangani M, Lavoie PM. Neonatal sepsis due to coagulase-negative staphylococci. Clin Dev Immunol 2013; 2013:586076.
15. Samarasekara SI, Booth D, Clarke P. Devastating coagulase-negative staphylococcal septicaemia in an extremely low birth weight infant. BMJ Case Rep 2012; 2012; 10.1136/bcr 007407.
16. Conner JM, Soll R, Edwards WH. Topical ointment for preventing infection in preterm infants. Cochrane Database Syst Rev 2004; 1:CD001150.
17. Edwards WH, Conner JM, Soll RF. The effect of prophylactic ointment therapy on nosocomial sepsis rates and skin integrity in infants of birth weight 501 to 1000g. Pediatrics 2004; 113:1195-1203.
18. Imdad A, Bautista RM, Senen KA, et al. Umbilical cord antiseptics for preventing sepsis and death among newborns. Cochrane Database Syst Rev 2013; 5:CD008635.
19. Canadian Agency for Drugs and Technologies in Health. Optimal in-hospital umbilical cord care for newborns: clinical evidence and guidelines. 2013. http://www.cadth.ca/media/pdf/htis/jul-2013/ RB0601%20Umbilical%20Cord%20Care%20Final.pdf. [Accessed 15 March 2014]
20. Lumbiganon P, Thinkhamrop J, Thinkhamrop B, Tolosa JE. Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding Group B streptococcal and HIV). Cochrane Database Syst Rev 2004; 4:CD004070.
21. Stade B, Shah V, Ohlsson A. Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection. Cochrane Database Syst Rev 2004; 3:CD003520.
22. Climo MW, Yokoe DS, Warren DK, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013; 368:533-542.
23. Milstone AM, Elward A, Song X, et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet 2013; 381:1099-1106.
24. Sankar MJ, Paul VK. Efficacy and safety of whole body skin cleansing with chlorhexidine in neonates: a systemic review. Pediatr Infect Dis J 2013; 32:e227-e234.
25. Ponnusamy V, Venkatesh V, Curley A, et al. Segmental percutaneous central venous line cultures for diagnosis of catheter-related sepsis. Arch Dis Child Fetal Neonatal Ed 2012; 97:F273-F278.
26. Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 2004; 30:62-67.
27. Narendran V, Gupta G, Todd DA, Jhon E. Bacterial colonisation of indwelling vascular catheters in newborn infants. J Paediatr Child Health 1996; 32:391-396.
28. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:1-45.
29. Ponnusamy V, Venkatesh V, Curley A, et al. Central venous catheter colonisation and catheter related sepsis: lessons learnt from exit site skin swab [abstract]. Arch Dis Child 2012; 97:A168.
30. Datta MK, Clarke P. Current practices in skin antisepsis for central venous catheterisation in UK tertiary-level neonatal units. Arch Dis Child Fetal Neonatal Ed 2008; 93:F328.
31. Tamma PD, Aucott SW, Milstone AM. Chlorhexidine use in the neonatal intensive care unit: results from a national survey. Infect Control Hosp Epidemiol 2010; 31:846-849.
32. Heron TJ, Faraday CM, Clarke P. The hidden harms of Matching Michigan. Arch Dis Child Fetal Neonatal Ed 2013; 98:F466-F467.
33. Shah D, Tracy M. Skin antisepsis survey in Australia-New Zealand neonatal nurseries. J Paediatr Child Health 2013; 49:601-602.
34. Davies GE, Francis J, Martin AR, et al. 1:6-di-4'- chlorophenyldiguanidohexane (hibitane). Laboratory investigation of a new antibacterial agent of high potency. Br J Pharmacol Chemother 1954; 9:192-196.
35. McDonnell G, Russell AD. Antiseptics disinfectants: activity action resistance. Clin Microbiol Rev 1999; 12:147-179.
36. Garland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001; 107:1431-1436.
37. Linder N, Prince S, Barzilai A, et al. Disinfection with 1% povidone-iodine versus 0.5% chlorhexidine gluconate in 70% isopropanol in the neonatal intensive care unit. Acta Paediatr 2004; 93:205-210.
38. Lilley C, Powls A, Gray A. A prospective randomised double blind comparison of 0.5% versus 0.05% aqueous chlorhexidine for skin antisepsis prior to line insertion in neonates. Arch Dis Child 2006; 91:A18.
39. Nuntnarumit P, Sangsuksawang N. A randomized controlled trial of 1% aqueous chlorhexidine gluconate compared with 10% povidone-iodine for topical antiseptic in neonates: effects on blood culture contamination rates. Infect Control Hosp Epidemiol 2013; 34:430-432.
40. Malathi I, Millar MR, Leeming JP, et al. Skin disinfection in preterm infants. Arch Dis Child 1993; 69:312-316.
41. European Medicines Agency. Chlorhexidine versus povidone-iodine for skin anitsepsis prior to central venous catheter insertion in preterm infants: protocol for a randomised trial. EudraCT Number: 2011-002962-19; 2011. https://www.clinicaltrialsregister.eu/ctr-search/search?queryeudract- number:2011-002962-19. [Accessed 15 March 2014]
42. National Library of Medicine (US). Efficacy study comparing 2% chlorhexidine in 70% isopropyl alcohol versus 2% aqueous chlorhexidine. ClinicalTrials. gov Identifier: NCT01270776; 2011-[updated 2013 May 13]. http://www.clinicaltrials.gov/ct2/show/study/NCT01270776?show-descY# desc. [Accessed 15 March 2014]
43. Brayer C, Micheau P, Bony C, et al. Neonatal accidental burn by isopropyl alcohol. Arch Pediatr 2004; 11:932-935.
44. Watkins AM, Keogh EJ. Alcohol burns in the neonate. J Paediatr Child Health 1992; 28:306-308.
45. Mannan K, Chow P, Lissauer T, Godambe S. Mistaken identity of skin cleansing solution leading to extensive chemical burns in an extremely preterm infant. Acta Paediatr 2007; 96:1536-1537.
46. Bringué Espuny X, Soria X, Solé E, et al. Chlorhexidine-methanol burns in two extreme preterm newborns. Pediatr Dermatol 2010; 27:676-678.
47. Reynolds PR, Banerjee S, Meek JH. Alcohol burns in extremely low birth-weight infants: still occurring. Arch Dis Child Fetal Neonatal Ed 2005; 90:F10.
48. Andersen C, Hart J, Vemgal P, Harrison C. Prospective evaluation of a multifactorial prevention strategy on the impact of nosocomial infection in very-low-birthweight infants. J Hosp Infect 2005; 61:162-167.
49. Lashkari HP, Chow P, Godambe S. Aqueous 2% chlorhexidine-induced chemical burns in an extremely premature infant. Arch Dis Child Fetal Neonatal Ed 2012; 97:F64.
50. Demir E, O'Dey DM, Pallua N. Accidental burns during surgery. J Burn Care Res 2006; 27:895-900.
51. Rutter N. Applied physiology: the newborn skin. Curr Paediatr 2003; 13:226-230.
52. Chapman AK, Aucott SW, Milstone AM. Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant. J Perinatol 2012; 32:4-9.
53. Garland JS, Alex CP, Uhing MR, et al. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates. J Perinatol 2009; 29:808-813.
54. Chapman AK, Aucott SW, Gilmore MM, et al. Absorption and tolerability of aqueous chlorhexidine gluconate used for skin antisepsis prior to catheter insertion in preterm neonates. J Perinatol 2013; 33:768-771.
55. Arabaci T, Turkez H, Canakci CF, Ozgoz M. Assessment of cytogenetic and cytotoxic effects of chlorhexidine digluconate on cultured human lympho cytes. Acta Odontol Scand 2013; 71:1255-1260.
56. Aitken J, Williams FL. A systematic review of thyroid dysfunction in preterm neonates exposed to topical iodine. Arch Dis Child Fetal Neonatal Ed 2014;99:F21-F28.
57. Harpin V, Rutter N. Percutaneous alcohol absorption and skin necrosis in a preterm infant. Arch Dis Child 1982; 57:477-479.
58. Darmstadt GL, Dinulos JG. Neonatal skin care. Pediatr Clin North Am 2000; 47:757-782.
59. Vivier PM, Lewander WJ, Martin HF, Linakis JG. Isopropyl alcohol intoxication in a neonate through chronic dermal exposure: a complication of a culturally-based umbilical care practice. Pediatr Emerg Care 1994; 10:91-93.
60. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002; 136:792-801.
61. Milstone AM, Passaretti CL, Perl TM. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 2008; 46:274-281.
62. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338:339-343.
63. Maiwald M, Chan ES. The forgotten role of alcohol: a systematic review and meta-analysis of the clinical efficacy and perceived role of chlorhexidine in skin antisepsis. PLoS One 2012; 7:e44277.
64. Loveday HP, Wilson JA, Pratt RJ, et al. epic3: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2014; 86:S1-70.
65. Hibbard JS, Mulberry GK, Brady AR. A clinical study comparing the skin antisepsis and safety of ChloraPrep, 70% isopropyl alcohol, and 2% aqueous chlorhexidine. J Infus Nurs 2002; 25:244-249.
66. Stevens PT, Schulman J. Evidence-based approach to preventing central line-associated bloodstream infection in the NICU. Acta Paediatr suppl 2012; 101:11-16.
67. Baumgartner C, Constant H, Putet G, Aulagner G. Cutaneous antiseptic efficacy of two ethanol chlorhexidine dilutions for neonatal venepuncture. J Pharm Clin-series 1998; 17:109-112.
68. Bowles S, Pettit J, Mickas N, et al. on behalf of the Perinatal Quality Improvement Panel (PQIP) and California Perinatal Quality Care Collaborative (CPQCC). Got a bug with nosocomial infection? Neonatal hospital-acquired infection prevention. 2007. https://cpqcc.org/documents/43/download. [Accessed 4 April 2014]